New
We are pleased to announce that John E. Harris, M.D., Ph.D., a distinguished vitiligo investigator from University of Massachusetts, was awarded with a grant by Dermatology Foundation to continue research on Skin-Resident Memory T Cells in Vitiligo. Last year, VRF has supported John Harris' project that aims to test some new substances for vitiligo treatment using his unique mouse model of vitiligo. If successful, this could be a critical step towards developing a new approach to vitiligo treatment.
FAQOther Questions
- Which skin conditions can be mistaken for vitiligo?
Vitiligo is a common skin condition with characteristic milky white patches of irregular shape. However, several other skin conditions exhibit similar symptoms that can lead to ...
- I have vitiligo: will my children have vitiligo, too?
If you have vitiligo, you might wonder about the chances of your children developing the condition. While there is a genetic component, vitiligo is not a straightforward heredit...
- Can chemicals cause vitiligo?
Certain chemicals can trigger vitiligo, leading to a condition known as chemical-induced vitiligo. While clinically and histologically indistinguishable from other types of viti...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.